link
Bookmarks
DES Exposure
Akram M. Shaaban, MBBCh; Nyree Griffin, MD, FRCR; Evis Sala, MD, PhD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
2
2
0

KEY FACTS

  • Terminology

    • Imaging

      • Top Differential Diagnoses

        • Pathology

          • Clinical Issues

            TERMINOLOGY

            • Definitions

              • Class VII müllerian duct anomaly based on Buttram & Gibbons and American Society for Reproductive Medicine revision
              • Due to in utero exposure to diethylstilboestrol (DES)

            IMAGING

            • General Features

              • Hysterosalpingography (HSG)

                • MR Findings

                  • Ultrasonographic Findings

                    DIFFERENTIAL DIAGNOSIS

                      PATHOLOGY

                      • General Features

                        CLINICAL ISSUES

                        • Natural History & Prognosis

                          • Treatment

                            DIAGNOSTIC CHECKLIST

                            • Consider

                              Selected References

                              1. Behr SC et al: Imaging of müllerian duct anomalies. Radiographics. 32(6):E233-50, 2012
                              2. Marcal L et al: Mullerian duct anomalies: MR imaging. Abdom Imaging. 36(6):756-64, 2011
                              3. Bermejo C et al: Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging. Ultrasound Obstet Gynecol. 35(5):593-601, 2010
                              4. Chandler TM et al: Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol. 82(984):1034-42, 2009
                              5. Olpin JD et al: Imaging of Müllerian duct anomalies. Clin Obstet Gynecol. 52(1):40-56, 2009
                              6. Steinkeler JA et al: Female infertility: a systematic approach to radiologic imaging and diagnosis. Radiographics. 29(5):1353-70, 2009
                              7. Deutch TD et al: The role of 3-dimensional ultrasonography and magnetic resonance imaging in the diagnosis of müllerian duct anomalies: a review of the literature. J Ultrasound Med. 27(3):413-23, 2008
                              8. Troiano RN et al: Mullerian duct anomalies: imaging and clinical issues. Radiology. 233(1):19-34, 2004
                              9. Imaoka I et al: MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics. 23(6):1401-21, 2003
                              10. Kruse K et al: Clinical implications of DES. Nurse Pract. 28(7 Pt 1):26-32,35, table of contents; quiz 35-7, 2003
                              11. Troiano RN: Magnetic resonance imaging of mullerian duct anomalies of the uterus. Top Magn Reson Imaging. 14(4):269-79, 2003
                              12. Swan SH: Intrauterine exposure to diethylstilbestrol: long-term effects in humans. APMIS. 108(12):793-804, 2000
                              13. Woodward PJ et al: MR imaging in the evaluation of female infertility. Radiographics. 13(2):293-310, 1993
                              14. Milhan D: DES exposure: implications for childbearing. Int J Childbirth Educ. 7(4):21-8, 1992
                              15. Carrington BM et al: Mullerian duct anomalies: MR imaging evaluation. Radiology. 176(3):715-20, 1990
                              16. Kaufman RH et al: Upper genital tract changes and infertility in diethylstilbestrol-exposed women. Am J Obstet Gynecol. 154(6):1312-8, 1986
                              17. Glaze GM: Diethylstilbestrol exposure in utero: review of literature. J Am Osteopath Assoc. 83(6):435-8, 1984
                              18. Nunley WC Jr et al: Upper reproductive tract radiographic findings in DES-exposed female offspring. AJR Am J Roentgenol. 142(2):337-9, 1984
                              19. Stillman RJ et al: Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril. 41(3):369-72, 1984
                              20. Haney AF et al: Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med. 28(12):851-6, 1983
                              21. Kaufman RH: Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol. Obstet Gynecol Annu. 11:187-202, 1982
                              22. Kinch RA: Diethylstilbestrol in pregnancy: an update. Can Med Assoc J. 127(9):812-3, 1982
                              23. Ben-Baruch G et al: Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders. Acta Obstet Gynecol Scand. 60(4):395-7, 1981
                              24. Berger MJ et al: Impaired reproductive performance in DES-exposed women. Obstet Gynecol. 55(1):25-7, 1980
                              25. Kaufman RH et al: Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol. 137(3):299-308, 1980
                              26. Rennell CL: T-shaped uterus in diethylstilbestrol (DES) exposure. AJR Am J Roentgenol. 132(6):979-80, 1979
                              Related Anatomy
                              Loading...
                              Related Differential Diagnoses
                              Loading...
                              References
                              Tables

                              Tables

                              KEY FACTS

                              • Terminology

                                • Imaging

                                  • Top Differential Diagnoses

                                    • Pathology

                                      • Clinical Issues

                                        TERMINOLOGY

                                        • Definitions

                                          • Class VII müllerian duct anomaly based on Buttram & Gibbons and American Society for Reproductive Medicine revision
                                          • Due to in utero exposure to diethylstilboestrol (DES)

                                        IMAGING

                                        • General Features

                                          • Hysterosalpingography (HSG)

                                            • MR Findings

                                              • Ultrasonographic Findings

                                                DIFFERENTIAL DIAGNOSIS

                                                  PATHOLOGY

                                                  • General Features

                                                    CLINICAL ISSUES

                                                    • Natural History & Prognosis

                                                      • Treatment

                                                        DIAGNOSTIC CHECKLIST

                                                        • Consider

                                                          Selected References

                                                          1. Behr SC et al: Imaging of müllerian duct anomalies. Radiographics. 32(6):E233-50, 2012
                                                          2. Marcal L et al: Mullerian duct anomalies: MR imaging. Abdom Imaging. 36(6):756-64, 2011
                                                          3. Bermejo C et al: Three-dimensional ultrasound in the diagnosis of Müllerian duct anomalies and concordance with magnetic resonance imaging. Ultrasound Obstet Gynecol. 35(5):593-601, 2010
                                                          4. Chandler TM et al: Mullerian duct anomalies: from diagnosis to intervention. Br J Radiol. 82(984):1034-42, 2009
                                                          5. Olpin JD et al: Imaging of Müllerian duct anomalies. Clin Obstet Gynecol. 52(1):40-56, 2009
                                                          6. Steinkeler JA et al: Female infertility: a systematic approach to radiologic imaging and diagnosis. Radiographics. 29(5):1353-70, 2009
                                                          7. Deutch TD et al: The role of 3-dimensional ultrasonography and magnetic resonance imaging in the diagnosis of müllerian duct anomalies: a review of the literature. J Ultrasound Med. 27(3):413-23, 2008
                                                          8. Troiano RN et al: Mullerian duct anomalies: imaging and clinical issues. Radiology. 233(1):19-34, 2004
                                                          9. Imaoka I et al: MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics. 23(6):1401-21, 2003
                                                          10. Kruse K et al: Clinical implications of DES. Nurse Pract. 28(7 Pt 1):26-32,35, table of contents; quiz 35-7, 2003
                                                          11. Troiano RN: Magnetic resonance imaging of mullerian duct anomalies of the uterus. Top Magn Reson Imaging. 14(4):269-79, 2003
                                                          12. Swan SH: Intrauterine exposure to diethylstilbestrol: long-term effects in humans. APMIS. 108(12):793-804, 2000
                                                          13. Woodward PJ et al: MR imaging in the evaluation of female infertility. Radiographics. 13(2):293-310, 1993
                                                          14. Milhan D: DES exposure: implications for childbearing. Int J Childbirth Educ. 7(4):21-8, 1992
                                                          15. Carrington BM et al: Mullerian duct anomalies: MR imaging evaluation. Radiology. 176(3):715-20, 1990
                                                          16. Kaufman RH et al: Upper genital tract changes and infertility in diethylstilbestrol-exposed women. Am J Obstet Gynecol. 154(6):1312-8, 1986
                                                          17. Glaze GM: Diethylstilbestrol exposure in utero: review of literature. J Am Osteopath Assoc. 83(6):435-8, 1984
                                                          18. Nunley WC Jr et al: Upper reproductive tract radiographic findings in DES-exposed female offspring. AJR Am J Roentgenol. 142(2):337-9, 1984
                                                          19. Stillman RJ et al: Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril. 41(3):369-72, 1984
                                                          20. Haney AF et al: Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med. 28(12):851-6, 1983
                                                          21. Kaufman RH: Structural changes of the genital tract associated with in utero exposure to diethylstilbestrol. Obstet Gynecol Annu. 11:187-202, 1982
                                                          22. Kinch RA: Diethylstilbestrol in pregnancy: an update. Can Med Assoc J. 127(9):812-3, 1982
                                                          23. Ben-Baruch G et al: Uterine anomalies in diethylstilbestrol-exposed women with fertility disorders. Acta Obstet Gynecol Scand. 60(4):395-7, 1981
                                                          24. Berger MJ et al: Impaired reproductive performance in DES-exposed women. Obstet Gynecol. 55(1):25-7, 1980
                                                          25. Kaufman RH et al: Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol. 137(3):299-308, 1980
                                                          26. Rennell CL: T-shaped uterus in diethylstilbestrol (DES) exposure. AJR Am J Roentgenol. 132(6):979-80, 1979